| Literature DB >> 31391944 |
Michelle Smekal1, Sarah Gil1, Maoliosa Donald1,2, Heather Beanlands3, Sharon Straus4,5, Gwen Herrington6, Dwight Sparkes6, Lori Harwood7, Allison Tong8, Allan Grill9, Karen Tu9, Blair Waldvogel6, Chantel Large6, Claire Large6, Marta Novak10, Matthew James1,2, Meghan Elliott1, Maria Delgado6, Scott Brimble11, Susan Samuel2,12, Brenda R Hemmelgarn1,2.
Abstract
BACKGROUND: Although numerous websites for patients with chronic kidney disease (CKD) are available, little is known about their content and quality.Entities:
Keywords: chronic kidney disease; internet; online; self-management; websites
Year: 2019 PMID: 31391944 PMCID: PMC6668187 DOI: 10.1177/2054358119863091
Source DB: PubMed Journal: Can J Kidney Health Dis ISSN: 2054-3581
Figure 1.CKD website review PRISMA flow diagram.
Note. CKD = chronic kidney disease.
aOther includes pdf documents, videos, clinic directories, veterinary clinics, practice guidelines, books, project descriptions.
Figure 2.Search engine results.
Note. CKD = chronic kidney disease.
Proportion of Websites Addressing Specific CKD Content (n = 115).
| Patient-identified information needs | n (%) |
|---|---|
| Understanding CKD | |
| Basic information about CKD, what causes it, how to assess risk, understanding eGFR | 107 (93.0) |
| Basic information about kidneys/kidney function | 93 (80.9) |
| How to slow progression of CKD | 88 (76.5) |
| What to expect as CKD progresses and overall implications on lifestyle | 61 (53.0) |
| Websites with at least 1 topic covered | 111 (96.5) |
| Symptoms | |
| What are the symptoms of CKD, what causes them | 89 (77.4) |
| What to expect as CKD progresses | 61 (53.0) |
| Considerations for comorbidities and impact of treatments for other conditions | 27 (23.5) |
| How to manage symptoms, and when to seek help | 24 (20.9) |
| Websites with at least 1 topic covered | 92 (80.0) |
| Diet | |
| Information about diet/nutritional requirements, what types of changes need to be made | 81 (70.4) |
| How to identify renal friendly/unfriendly foods | 41 (35.7) |
| How to make modifications to prepared or ethnic foods | 11 (9.6) |
| Practical tools for diet tracking | 10 (8.7) |
| Options for eating out, including considerations for those with diabetes | 6 (5.2) |
| Websites with at least 1 topic covered | 83 (72.2) |
| Mental & Physical Support | |
| Physical wellness—exercise/activities to slow progression, potential restrictions | 49 (42.6) |
| Mental wellness, specifically related to isolation, depression | 34 (29.6) |
| Emotional/social support resources and peer support (eg, online peer support, face-to-face, etc) | 27 (23.5) |
| How to communicate with others about mental health | 12 (10.4) |
| Screening tools for depression | 7 (6.1) |
| Websites with at least 1 topic covered | 61 (53.0) |
| Medications | |
| Common medications for CKD, their indications, side effects to watch for, and long-term effects | 59 (51.3) |
| How to manage side effects, interactions between medications (traditional and alternative) for other illnesses/conditions | 14 (12.2) |
| Websites with at least 1 topic covered | 60 (52.2) |
| Travel | |
| Things to consider regarding travel and CKD, potential limitations | 22 (19.1) |
| Insurance | 13 (11.3) |
| Accessing health care abroad | 10 (8.7) |
| What to bring | 7 (6.1) |
| Websites with at least 1 topic covered | 25 (21.7) |
| Finances | |
| Resources and potential short- and long-term expenses, considerations relating to reduced workforce participation, medication/insurance coverage | 14 (12.2) |
| Cost considerations (medications, equipment, food etc) | 4 (3.5) |
| Websites with at least 1 topic covered | 14 (12.2) |
| Work and School | |
| Accommodating the work/school environment | 13 (11.3) |
| How to discuss potential limitations with employer/school | 9 (7.8) |
| Supports and considerations for returning to work/retraining | 6 (5.2) |
| What should be disclosed and to whom (HR, teacher etc) | 4 (3.5) |
| Websites with at least 1 topic covered | 14 (12.2) |
Note. CKD = chronic kidney disease.
Website details including audience, rank, content and quality (n=115).
| • = Reported | Understanding CKD | Diet | Symptoms | Medications | Mental & physical support | Finances | Travel | Work & school | Proportion of content areas covered (%) | DISCERN (%) | LIDA | HONcode (%) | FRE (n/100) | FKRGL | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Website name: | Website URL | Audience | Website category | Website rank based on web traffic (Alexa Rank) | Basic information about kidneys/kidney function | Basic information about CKD, causes, how to assess risk, understanding eGFR | How to slow CKD progression | What to expect as CKD progresses and overall implications on lifestyle | Information about diet/ nutritional requirements and what types of changes need to be made | How to identify renal friendly/unfriendly foods | How to make modifications to prepared or ethnic foods. | Options for eating out, considerations for those with diabetes, | Practical tools for diet/lab tracking. | What are the symptoms of CKD, what causes them | What to expect as CKD progresses | How to manage symptoms, and when to seek help. | Considerations for comorbidities and impact of treatments for other conditions | Common medications for CKD, their indications, side effects to watch for/long term effects of medications | How to manage side effects, interactions between medications (traditional and alternative) for other illnesses/ conditions. | Mental wellness, isolation, depression | Screening tools for depression | How to communicate with others about mental health | Emotional/social support, resources and peer support | Physical wellness, exercise, activities to slow progression, potential restrictions | Resources for potential short- and long-term expenses relating to CKD (reduced work) | Cost considerations (medications, insurance, equipment, food etc) | Things to consider regarding travel and CKD, potential limitations | Insurance | Accessing health care abroad | What to bring | Accommodating the work/school environment | Supports and considerations for returning to work/retraining | How to discuss potential limitations with employer/school | What should be disclosed and to whom (HR, teacher) | Usability (%) | Reliability (%) | Total (%) | |||||
| Aboriginal Health Info Net |
| Patient | Academic/professional (universities, hospitals, and research centers) | 27 (24.1K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 10.0 | 77.8 | 76.9 | 75.9 | 76.5 | 78.6 | 39.1 | 12.7 |
| American Association of Kidney Patients |
| Patient | Nonprofit organizations, foundations, and charities | 93 (2.21M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 33.3 | 63.3 | 60.2 | 50.0 | 56.8 | 50.0 | 41.2 | 14.2 |
| American Heart Association |
| Both | Nonprofit organizations, foundations, and charities | 24 (10.5K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 13.3 | 77.8 | 76.9 | 75.9 | 76.5 | 92.9 | 53.3 | 11.0 |
| American Kidney Fund |
| Patient | Nonprofit organizations, foundations, and charities | 54 (141K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 46.7 | 72.2 | 91.7 | 74.1 | 85.8 | 85.7 | 79.7 | 5.5 |
| Australian Government Department of Health |
| Both | Academic/professional (universities, hospitals, and research centers) | 39 (46.8K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 13.3 | 75.6 | 68.5 | 75.9 | 71.0 | 82.1 | 33.2 | 15.6 |
| BC Government |
| Both | Academic/professional (universities, hospitals, and research centers) | 17 (7.76K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 30.0 | 78.9 | 68.5 | 61.1 | 66.0 | 75.0 | 13.1 | 17.1 |
| BC Renal Agency |
| Both | Academic/professional (universities, hospitals, and research centers) | 94 (2.26M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 50.0 | 78.9 | 86.1 | 74.1 | 82.1 | 85.7 | 53.0 | 9.3 |
| Better Health Victoria State Government |
| Patient | Academic/professional (universities, hospitals, and research centers) | 33 (35.7K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 13.3 | 76.7 | 70.4 | 74.1 | 71.6 | 85.7 | 53.6 | 9.6 |
| Bupa UK |
| Patient | Commercial and pharmaceutical companies | 45 (77.3K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 26.7 | 80.0 | 80.6 | 70.4 | 77.2 | 89.3 | 58.7 | 8.8 |
| CDC |
| Both | Academic/professional (universities, hospitals, and research centers) | 8 (2.20K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 16.7 | 77.8 | 81.5 | 85.2 | 82.7 | 89.3 | 57.5 | 9.2 |
| CESPHN |
| Both | Academic/professional (universities, hospitals, and research centers) | 90 (2.02M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 6.7 | 61.1 | 74.1 | 59.3 | 69.1 | 53.6 | 28.6 | 15.0 |
| Choosing Wisely |
| Both | Academic/professional (universities, hospitals, and research centers) | 70 (669K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 13.3 | 67.8 | 68.5 | 63.0 | 66.7 | 53.6 | 67.7 | 7.2 |
| CKD pathway |
| Provider | Academic/professional (universities, hospitals, and research centers) | 108 (6.34M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 16.7 | 81.1 | 80.6 | 75.9 | 79.0 | 67.9 | 37.6 | 14.2 |
| Cleveland clinic |
| Patient | Academic/professional (universities, hospitals, and research centers) | 20 (9.24K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 10.0 | 70.0 | 81.5 | 77.8 | 80.2 | 100.0 | 58.0 | 8.2 |
| CorHealth Ontario |
| Provider | Academic/professional (universities, hospitals, and research centers) | 107 (5.36M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 3.3 | 75.6 | 85.2 | 77.8 | 82.7 | 64.3 | 8.3 | 18.9 |
| Davita |
| Patient | Commercial and pharmaceutical companies | 41 (49.9K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 93.3 | 74.4 | 92.6 | 75.9 | 87.0 | 78.6 | 57.8 | 9.6 |
| Diabetes UK |
| Both | Nonprofit organizations, foundations, and charities | 52 (104K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 13.3 | 63.3 | 81.5 | 75.9 | 79.6 | 78.6 | 64.0 | 8.0 |
| DPC Education Center |
| Patient | Nonprofit organizations, foundations, and charities | 97 (2.63M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 53.3 | 65.6 | 75.9 | 74.1 | 75.3 | 82.1 | 58.0 | 9.9 |
|
|
| Patient | Commercial and pharmaceutical companies | 14 (3.16K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 30.0 | 70.0 | 72.2 | 74.1 | 72.8 | 100.0 | 44.6 | 11.6 |
| eMedicine Health |
| Patient | Commercial and pharmaceutical companies | 22 (10.1K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 36.7 | 63.3 | 77.8 | 79.6 | 78.4 | 100.0 | 46.2 | 11.4 |
| Fairview |
| Both | Nonprofit organizations, foundations, and charities | 37 (45.8K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 13.3 | 51.1 | 72.2 | 68.5 | 71.0 | 71.4 | 63.2 | 7.3 |
| Family Doctor |
| Both | Nonprofit organizations, foundations, and charities | 40 (49.4K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 23.3 | 75.6 | 88.0 | 75.9 | 84.0 | 100.0 | 74.1 | 5.2 |
| Fresenius Kidney Care |
| Patient | Commercial and pharmaceutical companies | 62 (411K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 66.7 | 66.7 | 87.0 | 75.9 | 83.3 | 71.4 | 55.7 | 10.2 |
| Fresenius Australia |
| Both | Commercial and pharmaceutical companies | 101 (2.96M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 13.3 | 55.6 | 74.1 | 66.7 | 71.6 | 60.7 | 36.2 | 12.3 |
| Fresenius Medical Care |
| Both | Commercial and pharmaceutical companies | 71 (769K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 20.0 | 62.2 | 88.9 | 75.9 | 84.6 | 75.0 | 52.9 | 9.9 |
| Good To Go Insurance |
| Patient | Commercial and pharmaceutical companies | 69 (656K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 16.7 | 43.3 | 56.5 | 46.3 | 53.1 | 42.9 | 58.3 | 9.5 |
| Guy’s & St. Thomas Kidney Patients’ Association |
| Patients | Nonprofit organizations, foundations, and charities | 58 (208K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 10.0 | 62.2 | 76.9 | 70.4 | 74.7 | 57.1 | 57.6 | 8.7 |
| HCA Healthcare |
| Both | Commercial and pharmaceutical companies | 56 (158K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 16.7 | 52.2 | 64.8 | 66.7 | 65.4 | 85.7 | 76.4 | 5.5 |
| Health Care Siemens—Australia |
| Both | Commercial and pharmaceutical companies | 72 (812K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 10.0 | 70.0 | 81.5 | 77.8 | 80.2 | 71.4 | 29.7 | 18.1 |
| Health Direct Australia |
| Patient | Academic/professional (universities, hospitals, and research centers) | 35 (44.1K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 13.3 | 81.1 | 76.9 | 88.9 | 80.9 | 92.9 | 52.4 | 10.2 |
| Health Insight Nevada |
| Both | Nonprofit organizations, foundations, and charities | 87 (1.66M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 0.0 | 65.6 | 71.3 | 66.7 | 78.4 | 78.6 | 20.3 | 15.6 |
| Health Line—CKD |
| Patient | Nonprofit organizations, foundations, and charities | 4 (529) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 20.0 | 67.8 | 74.1 | 74.1 | 74.1 | 96.4 | 50.1 | 8.8 |
| HealthLink BC |
| Patient | Academic/professional (universities, hospitals, and research centers) | 48 (91.1K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 36.7 | 78.9 | 77.8 | 85.2 | 80.2 | 85.7 | 63.8 | 7.6 |
| Health Services Executive |
| Both | Academic/professional (universities, hospitals, and research centers) | 36 (45K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 30.0 | 67.8 | 75.9 | 83.3 | 78.4 | 78.6 | 58.3 | 9.4 |
| Health& |
| Patient | Commercial and pharmaceutical companies | 88 (1.93M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 10.0 | 61.1 | 86.1 | 74.1 | 82.1 | 85.7 | 42.3 | 11.8 |
| Healthwise—Sask Health online |
| Patient | Academic/professional (universities, hospitals, and research centers) | 53 (113K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 30.0 | 80.0 | 74.1 | 94.4 | 80.9 | 78.6 | 69.4 | 6.5 |
| Info KID |
| Patient | Academic/professional (universities, hospitals, and research centers) | 85 (1.58M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 20.0 | 65.6 | 81.5 | 63.0 | 75.3 | 64.3 | 69.8 | 7.2 |
| Jama |
| Both | Academic/professional (universities, hospitals, and research centers) | 21 (9.32K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 16.7 | 71.1 | 78.7 | 83.3 | 80.2 | 92.9 | 43.5 | 11.4 |
| Kidney ABC (Tongshantang Hospital) |
| Patient | Commercial and pharmaceutical companies | 64 (492K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 20.0 | 41.1 | 71.3 | 44.4 | 62.3 | 32.1 | 59.8 | 7.7 |
| Kidney Care UK |
| Patient | Nonprofit organizations, foundations, and charities | 91 (2.02M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 60.0 | 83.3 | 94.4 | 77.8 | 88.9 | 71.4 | 48.5 | 12.2 |
| Kidney Cares Community (Tongshantang Hospital) |
| Patient | Commercial and pharmaceutical companies | 82 (1.23M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 20.0 | 35.6 | 67.6 | 46.3 | 60.5 | 42.9 | 43.4 | 12.1 |
| Kidney Disease (Tongshantang Hospital) |
| Patient | Commercial and pharmaceutical companies | 104 (3.64M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 20.0 | 40.0 | 74.1 | 51.9 | 66.7 | 42.9 | 41.8 | 13.1 |
| Kidney Disease Symptoms (Tongshantang Hospital) |
| Patient | Commercial and pharmaceutical companies | 81 (1.21M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 20.0 | 40.0 | 68.5 | 50.0 | 62.3 | 42.9 | 53.1 | 9.1 |
| Kidney Disease Treatment Center (Tongshantang Hospital) |
| Patient | Commercial and pharmaceutical companies | 99 (2.77M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 20.0 | 40.0 | 68.5 | 50.0 | 62.3 | 42.9 | 41.8 | 12.7 |
| Kidney Failure (Tongshantang Hospital) |
| Patient | Commercial and pharmaceutical companies | 76 (962K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 26.7 | 40.0 | 70.4 | 53.7 | 64.8 | 39.3 | 37.7 | 12.7 |
| Kidney Foundation of Canada |
| Patient/caregiver | Nonprofit organizations, foundations, and charities | 73 (846K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 63.3 | 70.0 | 88.9 | 51.9 | 76.5 | 64.3 | 47.1 | 11.4 |
| Kidney Health Australia |
| Both | Nonprofit organizations, foundations, and charities | 68 (617K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 53.3 | 73.3 | 90.7 | 81.5 | 87.7 | 78.6 | 39.1 | 12.2 |
| Kidney Patient Guide |
| Patient | Nonprofit organizations, foundations, and charities | 95 (2.39M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 50.0 | 79.4 | 86.1 | 72.2 | 81.5 | 92.9 | 56.4 | 9.2 |
| Kidney Research UK |
| Patient | Nonprofit organizations, foundations, and charities | 74 (869K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 20.0 | 66.7 | 79.6 | 63.0 | 74.1 | 78.6 | 50.7 | 11.0 |
| Kidney School |
| Both | Nonprofit organizations, foundations, and charities | 98 (2.71M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 36.7 | 70.0 | 84.3 | 59.3 | 75.9 | 64.3 | 71.4 | 7.1 |
| Kidney Services China (Tongshantang Hospital) |
| Patient | Commercial and pharmaceutical companies | 96 (2.41M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 23.3 | 40.0 | 64.8 | 25.9 | 51.9 | 39.3 | 47.3 | 11.2 |
| Kidney Support Network |
| Patient | Nonprofit organizations, foundations, and charities | 114 (14.4M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 13.3 | 48.9 | 77.8 | 51.9 | 69.1 | 50.0 | 51.1 | 9.2 |
| Kidney Treatment (Tongshantang Hospital) |
| Patient | Commercial and pharmaceutical companies | 84 (1.49M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 13.3 | 40.0 | 63.0 | 31.5 | 52.5 | 32.1 | 35.4 | 16.2 |
| Kidney Wales |
| Patient | Nonprofit organizations, foundations, and charities | 113 (13.9M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 16.7 | 64.4 | 75.0 | 57.4 | 69.1 | 57.1 | 58.6 | 9.0 |
| Kids Health |
| Both | Nonprofit organizations, foundations, and charities | 25 (10.7K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 23.3 | 75.6 | 89.8 | 81.5 | 87.0 | 85.7 | 50.2 | 10.7 |
| Lab Tests Online |
| Both | Commercial and pharmaceutical companies | 32 (31.1K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 20.0 | 81.1 | 74.1 | 74.1 | 74.1 | 100.0 | 48.9 | 10.9 |
| Life Line Screening |
| Patient | Commercial and pharmaceutical companies | 59 (293K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 6.7 | 65.6 | 82.4 | 66.7 | 77.2 | 64.3 | 36.3 | 10.8 |
| Life Options |
| patients | Nonprofit organizations, foundations, and charities | 60 (404K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 56.7 | 70.0 | 81.5 | 59.3 | 74.1 | 67.9 | 84.2 | 4.5 |
| London Health Sciences |
| Both | Academic/professional (universities, hospitals, and research centers) | 51 (103K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 50.0 | 75.6 | 85.2 | 74.1 | 81.5 | 71.4 | 42.9 | 11.7 |
| Long Island kidney and hypertension |
| Patient | Academic/professional (universities, hospitals, and research centers) | 112 (13.4M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 10.0 | 53.3 | 52.8 | 57.4 | 54.3 | 53.6 | 47.5 | 11.4 |
| Manitoba Renal Program |
| Both | Academic/professional (universities, hospitals, and research centers) | 105 (4.62M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 60.0 | 73.3 | 63.0 | 55.6 | 60.5 | 64.3 | 55.1 | 9.7 |
| Mayo clinic |
| Both | Nonprofit organizations, foundations, and charities | 7 (1.24K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 46.7 | 77.8 | 76.9 | 77.8 | 77.2 | 100.0 | 48.9 | 10.5 |
| Med Broadcast |
| Patient | Commercial and pharmaceutical companies | 44 (67.5K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 40.0 | 61.1 | 63.9 | 48.1 | 58.6 | 75.0 | 37.0 | 11.4 |
| Medical Dictionary |
| Unknown | Commercial and pharmaceutical companies | 6 (636) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 40.0 | 65.6 | 52.8 | 44.4 | 50.0 | 67.9 | 35.0 | 13.1 |
| Medical News Today |
| Both | Commercial and pharmaceutical companies | 10 (2.61K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 33.3 | 83.3 | 68.5 | 72.2 | 69.8 | 100.0 | 48.4 | 10.3 |
| Medicine Net |
| Patient | Commercial and pharmaceutical companies | 11 (2.86K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 50.0 | 77.8 | 71.3 | 77.8 | 73.5 | 100.0 | 45.2 | 12.0 |
| Medline Plus |
| Patient | Academic/professional (universities, hospitals, and research centers) | 13 (3.12K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 20.0 | 74.4 | 62.0 | 72.2 | 65.4 | 92.9 | 72.5 | 5.9 |
| MedScape |
| Clinician | Academic/professional (universities, hospitals, and research centers) | 9 (2.47K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 16.7 | 77.8 | 72.2 | 77.8 | 74.1 | 96.4 | 29.8 | 13.8 |
| Merck Manuals—professional (MSD) |
| Clinician | Commercial and pharmaceutical companies | 31 (27.8K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 33.3 | 82.2 | 73.1 | 75.9 | 74.1 | 82.1 | 14.0 | 16.2 |
| Merck Manuals-consumer (also MSD) |
| Patient | Commercial and pharmaceutical companies | 30 (27.7K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 30.0 | 71.1 | 69.4 | 70.4 | 69.8 | 82.1 | 33.9 | 12.9 |
| Mount Sinai |
| Both | Academic/professional (universities, hospitals, and research centers) | 29 (24.9K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 40.0 | 76.7 | 63.9 | 64.8 | 64.2 | 75.0 | 73.4 | 6.2 |
| My Doctor |
| Patient | Commercial and pharmaceutical companies | 46 (83.7K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 50.0 | 82.2 | 75.9 | 70.4 | 74.1 | 100.0 | 58.4 | 9.6 |
| My Kidney |
| Patient | Academic/professional (universities, hospitals, and research centers) | 100 (2.81M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 36.7 | 65.6 | 63.9 | 40.7 | 56.2 | 53.6 | 65.0 | 8.0 |
| My VMC |
| Both | Academic/professional (universities, hospitals, and research centers) | 50 (93.9K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 30.0 | 75.6 | 77.8 | 85.2 | 80.2 | 96.4 | 47.6 | 11.5 |
| MyHealth Alberta |
| Patient | Academic/professional (universities, hospitals, and research centers) | 26 (11.5K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 43.3 | 83.3 | 77.8 | 81.5 | 79.0 | 85.7 | 67.7 | 6.8 |
| NIDDK |
| Both | Academic/professional (universities, hospitals, and research centers) | 2 (153) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 60.0 | 80.0 | 73.1 | 79.6 | 66.0 | 82.1 | 69.1 | 6.7 |
| National Kidney Center |
| Patient | Nonprofit organizations, foundations, and charities | 83 (1.25M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 36.7 | 72.2 | 65.7 | 63.0 | 64.8 | 71.4 | 58.9 | 8.7 |
| National Kidney Federation UK |
| Patient | Nonprofit organizations, foundations, and charities | 77 (981K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 40.0 | 68.9 | 77.8 | 70.4 | 75.3 | 78.6 | 60.6 | 9.3 |
| National Kidney Foundation |
| Both | Nonprofit organizations, foundations, and charities | 42 (50.4K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 76.7 | 77.8 | 66.7 | 53.7 | 62.3 | 92.9 | 55.2 | 9.1 |
| National Kidney Foundation of Illinois |
| Both | Nonprofit organizations, foundations, and charities | 89 (2.01M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 26.7 | 62.2 | 75.9 | 64.8 | 72.2 | 67.9 | 53.2 | 9.5 |
| Nephcure |
| Both | Nonprofit organizations, foundations, and charities | 78 (1.0M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 50.0 | 74.4 | 51.9 | 37.0 | 46.9 | 75.0 | 49.6 | 10.7 |
| Net Wellness |
| Unknown | Nonprofit organizations, foundations, and charities | 75 (912K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 26.7 | 73.3 | 83.3 | 81.5 | 82.7 | 75.0 | 36.2 | 13.6 |
| NHS |
| Patient | Academic/professional (universities, hospitals, and research centers) | 15 (3.36K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 50.0 | 74.4 | 77.8 | 79.6 | 78.4 | 92.9 | 62.4 | 8.7 |
| NHS Inform |
| Patient | Academic/professional (universities, hospitals, and research centers) | 47 (85.0K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 56.7 | 76.7 | 66.7 | 63.0 | 65.4 | 89.3 | 59.1 | 9.1 |
| NI Direct Government Services |
| Both | Academic/professional (universities, hospitals, and research centers) | 34 (42.5K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 20.0 | 68.9 | 77.8 | 88.9 | 81.5 | 71.4 | 61.0 | 8.4 |
| NICE Pathways UK |
| Both | Academic/professional (universities, hospitals, and research centers) | 28 (24.6K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 30.0 | 87.8 | 80.6 | 79.6 | 80.2 | 82.1 | 33.9 | 13.2 |
| NRS Healthcare |
| Patient | Commercial and pharmaceutical companies | 63 (481K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 36.7 | 61.1 | 61.1 | 50.0 | 57.4 | 64.3 | 50.7 | 11.6 |
| Ontario Renal Network |
| Both | Academic/professional (universities, hospitals, and research centers) | 109 (7.2M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 23.3 | 70.0 | 74.1 | 64.8 | 71.0 | 78.6 | 51.8 | 9.7 |
| Patient |
| Both | Nonprofit organizations, foundations, and charities | 19 (9.02K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 40.0 | 84.4 | 75.9 | 79.6 | 77.2 | 100.0 | 51.5 | 9.9 |
| PHN Central and Eastern Australia |
| Both | Academic/professional (universities, hospitals, and research centers) | 92 (2.02M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 3.3 | 58.9 | 64.8 | 59.3 | 61.7 | 53.6 | 26.6 | 17.4 |
| Renal Support Network |
| Both | Nonprofit organizations, foundations, and charities | 86 (1.62M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 60.0 | 58.9 | 66.7 | 53.7 | 62.3 | 60.7 | 54.0 | 9.6 |
| Rexall |
| Patient | Commercial and pharmaceutical companies | 55 (146K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 30.0 | 61.1 | 67.6 | 55.6 | 63.6 | 60.7 | 46.3 | 12.1 |
| Rogosin Institute |
| Both | Academic/professional (universities, hospitals, and research centers) | 106 (4.65M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 6.7 | 58.9 | 74.1 | 44.4 | 64.2 | 57.1 | 41.2 | 11.9 |
| Saskatoon Health Region |
| Patient | Academic/professional (universities, hospitals, and research centers) | 66 (537K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 23.3 | 73.3 | 67.6 | 68.5 | 67.9 | 85.7 | 51.2 | 10.3 |
| Scottish Kidney Federation[ |
| Patient | Nonprofit organizations, foundations, and charities | NA | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | n/a | 57.8 | 69.4 | 57.4 | 65.4 | 60.7 | 39.7 | 12.0 | |||||||||||||
| Shire Canada |
| Patient | Commercial and pharmaceutical companies | 103 (3.59M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 10.0 | 57.8 | 69.4 | 57.4 | 65.4 | 60.7 | 39.7 | 12.0 |
| St Agnes Surgery |
| Patient | Academic/professional (universities, hospitals, and research centers) | 110 (8.09M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 23.3 | 55.6 | 68.5 | 46.3 | 61.1 | 67.9 | 32.3 | 15.2 |
| Standford Healthcare |
| Both | Academic/professional (universities, hospitals, and research centers) | 38 (46.2K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 10.0 | 66.7 | 73.1 | 57.4 | 67.9 | 67.9 | 46.4 | 9.8 |
| Sunnybrook hospital |
| Patient | Academic/professional (universities, hospitals, and research centers) | 49 (93.8K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 13.3 | 75.6 | 79.6 | 64.8 | 74.7 | 75.0 | 38.0 | 9.4 |
| The Renal Association |
| Clinician | Academic/professional (universities, hospitals, and research centers) | 65 (520K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 60.0 | 82.2 | 75.0 | 72.2 | 74.1 | 82.1 | 39.9 | 13.5 |
| The Royal Melbourne Hospital |
| Both | Academic/professional (universities, hospitals, and research centers) | 61 (405K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 6.7 | 67.8 | 71.3 | 68.5 | 70.4 | 78.6 | 35.7 | 12.9 |
| Think Kidneys |
| Patient | Nonprofit organizations, foundations, and charities | 102 (3.22M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 23.3 | 71.1 | 79.6 | 66.7 | 75.3 | 67.9 | 60.9 | 9.4 |
| UC San Diego Health |
| Patient | Academic/professional (universities, hospitals, and research centers) | 12 (2.95K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 43.3 | 78.9 | 75.9 | 70.4 | 74.1 | 75.0 | 45.7 | 11.1 |
| UCSF Department of surgery |
| Both | Academic/professional (universities, hospitals, and research centers) | 18 (8.53K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 33.3 | 72.2 | 72.2 | 68.5 | 71.0 | 85.7 | 72.8 | 6.4 |
| UNC Kidney Center |
| Both | Academic/professional (universities, hospitals, and research centers) | 79 (1.07M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 40.0 | 66.7 | 70.4 | 59.3 | 66.7 | 71.4 | 56.8 | 9.3 |
| UptoDate |
| Both | Commercial and pharmaceutical companies | 16 (5.23K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 23.3 | 83.3 | 59.3 | 92.6 | 70.4 | 82.1 | 42.3 | 11.3 |
| UW Health |
| Patient | Academic/professional (universities, hospitals, and research centers) | 43 (59.8K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 40.0 | 66.7 | 63.9 | 59.3 | 62.3 | 60.7 | 67.7 | 6.8 |
| Very Well Health |
| Patient | Nonprofit organizations, foundations, and charities | 23 (10.4K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 43.3 | 86.7 | 84.3 | 85.2 | 84.6 | 100.0 | 42.3 | 13.1 |
| Web MD |
| Both | Commercial and pharmaceutical companies | 5 (599) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 33.3 | 71.1 | 84.3 | 85.2 | 84.6 | 100.0 | 68.0 | 7.2 |
| Welling Homeopathy |
| Patient | Commercial and pharmaceutical companies | 67 (569K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 16.7 | 35.6 | 66.7 | 50.0 | 61.1 | 42.9 | 39.0 | 13.6 |
| Western Nephrology |
| Both | Academic/professional (universities, hospitals, and research centers) | 111 (11.8M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 10.0 | 52.2 | 74.1 | 40.7 | 63.0 | 64.3 | 38.2 | 12.8 |
| Wiki How |
| Patient | Commercial and pharmaceutical companies | 3 (179) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 6.7 | 68.9 | 74.1 | 85.2 | 77.8 | 78.6 | 58.3 | 8.9 |
| Wikipedia |
| Both | Nonprofit organizations, foundations, and charities | 1 (5) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 26.7 | 72.2 | 71.3 | 79.6 | 74.1 | 92.9 | 18.5 | 14.5 |
| World Kidney Day |
| Patient | Nonprofit organizations, foundations, and charities | 80 (1.13M) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 26.7 | 64.4 | 81.5 | 64.8 | 75.9 | 60.7 | 50.9 | 10.0 |
| Your MD |
| Patient | Commercial and pharmaceutical companies | 57 (196K) | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | 46.7 | 73.3 | 82.4 | 79.6 | 81.5 | 75.0 | 60.7 | 8.1 |
Note. CKD = chronic kidney disease; FRE = Flesch Reading Ease; FKRGL = Flesch-Kincaid Reading Grade Level; eGFR = estimated glomerular filtration rate; CDC = Centers for Disease Control and Prevention; CESPHN = Central and Eastern Sydney Primary Health Network; DPC = Dialysis Patient Citizens; VMC = Virtual Medical Center; NIDDK = National Institute of Diabetes and Digestive and Kidney Diseases; NHS = National Health Service.
Website became unavailable during evaluation.
Website link no longer accessible on 9 July 2019.
Mean Quality and Readability Assessment Scores for Reviewed Sites (n = 115).
| Measurement | Mean score |
|---|---|
| DISCERN | |
| Are the aims clear? | 79.0 (7.9) |
| Does it achieve its aims? | 73.0 (10.6) |
| Is it relevant? | 70.0 (11.4) |
| Is it clear what sources of information were used to compile the publication (other than the author or producer)? | 62.4 (19.3) |
| Is it clear when the information used or reported in the publication was produced? | 63.5 (20.4) |
| Is it balanced and unbiased? | 66.1 (14.4) |
| Does it provide details of additional sources of support and information? | 68.3 (19.6) |
| Does it refer to areas of uncertainty? | 62.5 (13.6) |
| Overall rating of the publication | 67.9 (14.6) |
| DISCERN total score | 68.1 (14.6) |
| LIDA | |
| Clarity | 77.3 (10.9) |
| Consistency | 82.4 (10.9) |
| Functionality | 79.2 (7.6) |
| Engagability | 57.1 (14.7) |
| Currency | 50.9 (14.8) |
| Conflicts of interest | 86.4 (14.2) |
| Content production | 63.9 (20.4) |
| LIDA total score | 71.0 (14.4) |
| HON code | 74.6 (17.2) |
| FRE | Mean FRE (±SD) |
| FKRGL | Mean Grade (±SD) |
Note. FRE = Flesch Reading Ease; FKRGL = Flesch-Kincaid Reading Grade Level.
Top 10 Websites According to Quality Criteria[a].
| Overall rank | DISCERN (%) | LIDA | Readability | ||
|---|---|---|---|---|---|
| Usability (%) | Reliability (%) | Flesch reading ease | Flesch-Kincaid reading grade level | ||
| 1 | NICE Pathways UK (87.78) | Kidney Care UK (94.4) | Health Wise Saskatchewan (94.4) | Life Options (84.2) | Life Options (4.5) |
| 2 | Very Well Health (86.67) | Davita (92.6) | UpToDate (92.6) | American Kidney Fund (79.7) | Family Doctor (5.2) |
| 3 | Patient (84.44) | American Kidney Fund (91.7) | NI Direct Government Services (88.9) | HCA Healthcare (76.4) | American Kidney Fund (5.5) |
| 4 | Medical News Today (83.33) | Kidney Health Australia (90.7) | Health Direct Australia (88.9) | Family Doctor (74.1) | HCA Healthcare (5.5) |
| 5 | UpToDate (83.33) | Kids Health (89.8) | Very Well Health (85.2) | Mount Sinai (73.4) | Medline Plus (5.9) |
| 6 | MyHealth Alberta (83.33) | Kidney Foundation of Canada (88.9) | Web MD (85.2) | UCSF Department of Surgery (72.8) | UCSF Department of Surgery (6.4) |
| 7 | Kidney Care UK (83.33) | Fresenius Medical Care (87) | CDC (85.2) | Medline Plus (72.5) | Health Wise Saskatchewan (6.5) |
| 8 | Merck Manuals—Professional (82.22) | Kidney Patient Guide (86.1) | HealthLink BC (85.2) | Kidney School (71.4) | NIDDK (6.7) |
| 9 | My Doctor (82.22) | BC Renal Agency (86.1) | My Virtual Medical Center (85.2) | Info KID (69.8) | MyHealth Alberta (6.8) |
| 10 | The Renal Association (82.22) | Health& (86.1) | Wiki How (85.2) | Health Wise Saskatchewan (69.4) | UW Health (6.8) |
Note. CDC = Centers for Disease Control and Prevention; NIDDK = National Institute of Diabetes and Digestive and Kidney Diseases.
HON Code—12 websites scored 100.0%: Cleveland Clinic; Drugs.com; eMedicine Health; Family Doctor; Lab Tests Online; Mayo Clinic; Medical News Today; Medicine Net; My Doctor; Patient; Very Well Health; WebMD.
Top 10 Websites According to Website Traffic (Alexa Rank).
| Website name | Website rank based on web traffic (Alexa Rank) | Proportion of content areas covered (%) | DISCERN (%) | LIDA | HON code (%) | Readability | ||
|---|---|---|---|---|---|---|---|---|
| Usability (%) | Reliability (%) | Flesch reading ease | Flesch–Kincaid reading grade level | |||||
| Wikipedia | 1 (5) | 26.7 | 72.22 | 71.3 | 79.6 | 92.9 | 18.5 | 14.5 |
| NIDDK | 2 (153) | 60.0 | 80 | 73.1 | 79.6 | 82.1 | 69.1 | 6.7 |
| Wiki How | 3 (179) | 6.7 | 68.89 | 74.1 | 85.2 | 78.6 | 58.3 | 8.9 |
| Health Line–CKD | 4 (529) | 20.0 | 67.78 | 74.1 | 74.1 | 96.4 | 50.1 | 8.8 |
| Web MD | 5 (599) | 33.3 | 71.11 | 84.3 | 85.2 | 100.0 | 68.0 | 7.2 |
| Medical Dictionary | 6 (636) | 40.0 | 65.56 | 52.8 | 44.4 | 67.9 | 35.0 | 13.1 |
| Mayo clinic | 7 (1240) | 46.7 | 77.78 | 76.9 | 77.8 | 100.0 | 48.9 | 10.5 |
| CDC | 8 (2200) | 16.7 | 77.78 | 81.5 | 85.2 | 89.3 | 57.5 | 9.2 |
| MedScape | 9 (2470) | 16.7 | 77.78 | 72.2 | 77.8 | 96.4 | 29.8 | 13.8 |
| Medical News Today | 10 (2610) | 33.3 | 83.33 | 68.5 | 72.2 | 100.0 | 48.4 | 10.3 |
Note. NIDDK = National Institute of Diabetes and Digestive and Kidney Diseases; CKD = chronic kidney disease; CDC = Centers for Disease Control and Prevention.